Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion
A. M. Patiño-Trives(Instituto Maimónides de Investigación Biomédica de Córdoba), Dario Roccatello(5T Torino (Italy)), Irene Cecchi(Ospedale San Giovanni Bosco), Savino Sciascia(Ospedale San Giovanni Bosco), Nuria Barbarroja(Instituto Maimónides de Investigación Biomédica de Córdoba), Laura Pérez‐Sánchez(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), Massimo Radin(Ospedale San Giovanni Bosco), M. Á. Aguirre(Instituto Maimónides de Investigación Biomédica de Córdoba), C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), I. Arias de la Rosa(Instituto Maimónides de Investigación Biomédica de Córdoba), M. Luque-Tévar(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Escudero‐Contreras(Instituto Maimónides de Investigación Biomédica de Córdoba), Rafaela Ortega(Instituto Maimónides de Investigación Biomédica de Córdoba), María Carmen Castro(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 22
Related Papers
GAPSS: the Global Anti-Phospholipid Syndrome Score
|Lara D. Veeken|2013|310
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
|Nature Communications|2021|166
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
|Seminars in Thrombosis and Hemostasis|2017|125
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
|Journal of Thrombosis and Haemostasis|2011|120